UnitedHealth Group's acquisition of Amedisys has been authorized by the DOJ, despite a Biden-era legal challenge. The agreement requires UnitedHealth to divest 164 home health and hospice locations across 19 states and imposes a $1.1 million penalty on Amedisys for inaccuracies in compliance reporting. Senators Wyden and Warren have launched an investigation into UnitedHealth, focusing on the company's practices regarding nursing care cost reductions. Warren criticized the merger settlement, indicating that it could favor corporate interests over the wellbeing of vulnerable patients.
"Big Medicine will profit at the expense of vulnerable hospice patients," one health care analyst said. This reflects concerns that corporate mergers may compromise patient care.
The DOJ's Antitrust Division settled a Biden-era legal challenge, allowing UnitedHealth to acquire Amedisys but requiring divestment of 164 locations across 19 states.
Collection
[
|
...
]